Faculty

Institution

Unit

Venue

Victor Eduardo Mulanovich

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Infectious Diseases

The University of Texas MD Anderson Cancer Center

Victor Eduardo Mulanovich is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on transplant infectious diseases, particularly cytomegalovirus and adenovirus infections in hematopoietic cell transplant recipients, as well as infections complicating chimeric antigen receptor T-cell therapy. His recent work includes studies on maribavir for refractory cytomegalovirus infection, cytokine storms in COVID-19 and CAR-T therapy, and toxoplasmosis prophylaxis in allogeneic stem cell transplantation. He has also investigated Whipple's disease in immunocompromised patients and the implementation of automated antibiotic time-outs in cancer centers. His contributions span oncology, hematology, and immunology, with a strong emphasis on optimizing infection management in severely immunocompromised populations.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Victor Eduardo Mulanovich

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

infectious diseases medicine hematology hospital infections transplant infectious diseases immunology infectious diseases (medical specialty) oncology bone marrow transplantation transplantation medicine medical virology clinical transplantation infection control stem cell transplantation cell transplantation medical mycology antibiotics clinical microbiology epidemiology organ transplantation clinical infection clinical infectious disease covid-19 virology pathogens hematological malignancies antiviral therapy clinical mycology virus research cancer patients antimicrobial agents leukemia cancer care infectious respiratory disease antimicrobial stewardship comprehensive cancer center respiratory infections antiviral research thoracic oncology antimicrobial chemotherapy cancer treatment communicable diseases myeloid neoplasia viral persistence clinical immunology covid-19 pandemic cancer management lymphoid neoplasia risk factors emerging infectious diseases antimicrobial susceptibility medical microbiology antibiotic resistance disease transmission microbial disease immune reconstitution acute myeloid leukemia progressive multifocal leukoencephalopathy graft survival treatment and prevention antifungal agents cord blood bone marrow failure antiviral drugs hematopoietic recovery hiv-infected patients invasive fungal infections treatment modalities hematologic malignancies immunologic diseases immunohaematology early outcomes axicabtagene ciloleucel large b-cell lymphoma influenza infections respiratory viral infections

Notable Scholarly Works

Notable Federal Grants

Collaborators

Administration of Off-The-Shelf, Expanded, Most Closely Hla Matched, Third Party Viral Specific T Cells for the Therapy of Adenovirus Related Disease in Adult Immunocompromised Patients.. Blood (2025)

virologycellular therapymedicinecell therapyinfectious diseasesmedical virologyimmunotherapyadenovirus related diseaseimmunologyimmunity (medicine)cell transplantationantiviral responsesantiviral therapyadult immunocompromised patients

Cytokine Storms in Covid-19, Hemophagocytic Lymphohistiocytosis, and Car-T Therapy. JAMA Network Open (2025)

cytokine stormsimmune responsescovid-19cellular therapyinfectious diseasesmedical virologyclinical immunologyimmunologycell transplantationimmunosuppression

Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transplant Infectious Disease (2025)

hematologymedicineantiviral researchinfectious diseaseshematologic malignancy patientsmedical virologybone marrow transplantationreal‐world experienceinfectious diseases (medical specialty)stem cell transplantationtransplant infectious diseasesantiviral therapyresistant cytomegalovirus infectiontransplantation medicine

Whipple's Disease in a Patient With Follicular Lymphoma. Diagnostic Microbiology and Infectious Disease (2025)

histopathologyanatomical pathologylymphatic diseaselymphoid neoplasiahuman pathologyfollicular lymphomapathology

Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infectious Diseases (2024)

Fareed KhawajaSairah AhmedSwaminathan P IyerJoseph SassineGuy HandleyRishab PrakashTracy VanWierrenJennifer JacksonAnna ZubovskaiaJeremy RamdialGabriela RondonKrina K PatelAmy SpalloneElla J Ariza-HerediaVictor MulanovichGeorgios AngelidakisYing JiangRoy F Chemaly

hematologycytomegaloviral infectionsoncologyoncologic outcomesinfectious diseasesregional studiesimmunologyoutcomes researchobservational study

Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases (2024)

microbiologyantibiotic resistancemedicineantimicrobial agentscancer researchoncologyinfection controlantimicrobial chemotherapyautomated antibiotic time-outhospital infectionsantimicrobial susceptibilityantibioticsantimicrobial stewardshipcomprehensive cancer centerantimicrobial resistance

Outcomes of Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Antimicrobial Prophylaxis. Bone Marrow Transplantation (2024)

Alexandre E. MalekTaha Al-JuhaishiDenái R. MiltonJeremy L. RamdialMay DaherAmanda L. OlsonSamer A. SrourGheath AlatrashBetul OranRohtesh S. MehtaIssa F. KhouriQaiser BashirNina ShahStefan O. CiureaGabriela RondonFarzaneh MaadaniChitra HosingDavid MarinPartow KebriaeiKatayoun RezvaniYago NietoPaolo AnderliniAmin M. AlousiMuhammad Salman FaisalMuzaffar H. QazilbashUday R. PopatRichard E. ChamplinElizabeth J. ShpallVictor E. MulanovichSairah Ahmed

hematologyclinical infectionorgan transplantationmedicineclinical transplantationinfectious diseasesbone marrow transplantationclinical microbiologyregenerative medicineoutcomes researchcell transplantationtransplantation medicinetransplant infectious diseasesstem cell transplantationmedical microbiologyantimicrobial prophylaxisepidemiology

The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease (2024)

Marjorie V. BatistaJoseph SassineFareed KhawajaPrathit A. KulkarniGeorgios AngelidakisJoumana KmeidFiras El ChaerElla J. Ariza‐HerediaEdward A. GravissVictor E. MulanovichRoy F. Chemaly

interferon-g release assaystuberculosismedicineclinical infectious diseaseinfectious diseasestransplant infectious diseases

Differing Inflammatory Profiles and Survival Outcomes of Cytokine Storm Arising From Car T-Cell Therapy, Covid and Malignancy-Associated Hlh in Patients With Hematological Malignancies. Blood (2023)

Anath LionelJames LongRishab PrakashPaul EdelkampMark KnaflSairah AhmedPaolo StratiRanjit NairKelly S. ChienDai ChiharaJason WestinFareed KhawajaLoretta J. NastoupilJoanna-Grace ManzanoVictor MulanovichDCODE TeamNaval DaverAndrew FutrealScott E. WoodmanChristopher R. FlowersSattva S. NeelapuSwami P. Iyer

chronic inflammationmedicineautoimmune diseasescancer immunosurveillancecritical carecar t-cell therapycellular therapysurvival outcomesimmunotherapycancer careclinical immunologycytokine stormimmune responsesbone marrow transplantationimmunologyinflammatory profileshematologycovid-19hematological malignanciescancer cellsmalignant blood disordersclinical rheumatologymalignancy-associated hlh

International Multicenter Study Comparing Covid-19 in Patients With Cancer to Patients Without Cancer: Impact of Risk Factors and Treatment Modalities on Survivorship. eLife (2023)

covid-19oncologycovid-19 pandemicrisk factorscancer managementtreatment modalitiescancer carepublic healthsupportive careepidemiologyinternational multicenter study

1
2
3
4
5
12
10 / page

Victor Eduardo Mulanovich

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Infectious Diseases

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Victor Eduardo Mulanovich

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cytokine Storms in Covid-19, Hemophagocytic Lymphohistiocytosis, and Car-T Therapy. JAMA Network Open (2025)

cytokine stormsimmune responsescovid-19cellular therapyinfectious diseasesmedical virologyclinical immunologyimmunologycell transplantationimmunosuppression

Whipple's Disease in a Patient With Follicular Lymphoma. Diagnostic Microbiology and Infectious Disease (2025)

histopathologyanatomical pathologylymphatic diseaselymphoid neoplasiahuman pathologyfollicular lymphomapathology

Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infectious Diseases (2024)

hematologycytomegaloviral infectionsoncologyoncologic outcomesinfectious diseasesregional studiesimmunologyoutcomes researchobservational study

Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases (2024)

Outcomes of Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Antimicrobial Prophylaxis. Bone Marrow Transplantation (2024)

The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer. Transplant Infectious Disease (2024)

Marjorie V. BatistaJoseph SassineFareed KhawajaPrathit A. KulkarniGeorgios AngelidakisJoumana KmeidFiras El ChaerElla J. Ariza‐HerediaEdward A. GravissVictor E. MulanovichRoy F. Chemaly

interferon-g release assaystuberculosismedicineclinical infectious diseaseinfectious diseasestransplant infectious diseases

International Multicenter Study Comparing Covid-19 in Patients With Cancer to Patients Without Cancer: Impact of Risk Factors and Treatment Modalities on Survivorship. eLife (2023)

covid-19oncologycovid-19 pandemicrisk factorscancer managementtreatment modalitiescancer carepublic healthsupportive careepidemiologyinternational multicenter study

1
2
3
4
5
12
10 / page